Trudeau ME - Search Results

1

The Temporal Risk of Heart Failure Associated With Adjuvant Trastuzumab in Breast Cancer Patients: A Population Study.

Goldhar HA, Yan AT, Ko DT, Earle CC, Tomlinson GA, Trudeau ME, Krahn MD, Krzyzanowska MK, Pal RS, Brezden-Masley C, Gavura S, Lien K, Chan KK. Goldhar HA, et al. Among authors: trudeau me. J Natl Cancer Inst. 2015 Oct 16;108(1):djv301. doi: 10.1093/jnci/djv301. Print 2016 Jan. J Natl Cancer Inst. 2015. PMID: 26476433

2

Docetaxel in patients with metastatic breast cancer: a phase II study of the National Cancer Institute of Canada-Clinical Trials Group.

Trudeau ME, Eisenhauer EA, Higgins BP, Letendre F, Lofters WS, Norris BD, Vandenberg TA, Delorme F, Muldal AM. Trudeau ME, et al. J Clin Oncol. 1996 Feb;14(2):422-8. doi: 10.1200/JCO.1996.14.2.422. J Clin Oncol. 1996. PMID: 8636752 Clinical Trial.

3

Optimizing adjuvant breast cancer chemotherapy: rationale for the MA.21 study.

Trudeau ME. Trudeau ME. Oncology (Williston Park). 2001 May;15(5 Suppl 7):7-13. Oncology (Williston Park). 2001. PMID: 11396366 Free article. Review.

4

Incidence and prognostic impact of amenorrhea during adjuvant therapy in high-risk premenopausal breast cancer: analysis of a National Cancer Institute of Canada Clinical Trials Group Study--NCIC CTG MA.5.

Parulekar WR, Day AG, Ottaway JA, Shepherd LE, Trudeau ME, Bramwell V, Levine M, Pritchard KI; National Cancer Institute of Canada Clinical Trials Group. Parulekar WR, et al. Among authors: trudeau me. J Clin Oncol. 2005 Sep 1;23(25):6002-8. doi: 10.1200/JCO.2005.07.096. J Clin Oncol. 2005. PMID: 16135468

5

Selection of adjuvant chemotherapy for treatment of node-positive breast cancer.

Trudeau M, Charbonneau F, Gelmon K, Laing K, Latreille J, Mackey J, McLeod D, Pritchard K, Provencher L, Verma S. Trudeau M, et al. Lancet Oncol. 2005 Nov;6(11):886-98. doi: 10.1016/S1470-2045(05)70424-1. Lancet Oncol. 2005. PMID: 16257797 Review.

6

Cost-effectiveness of switching to exemestane versus continued tamoxifen as adjuvant therapy for postmenopausal women with primary breast cancer.

Risebrough NA, Verma S, Trudeau M, Mittmann N. Risebrough NA, et al. Cancer. 2007 Aug 1;110(3):499-508. doi: 10.1002/cncr.22824. Cancer. 2007. PMID: 17592825 Free article.

7

Triple-negative breast cancer: clinical features and patterns of recurrence.

Dent R, Trudeau M, Pritchard KI, Hanna WM, Kahn HK, Sawka CA, Lickley LA, Rawlinson E, Sun P, Narod SA. Dent R, et al. Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4429-34. doi: 10.1158/1078-0432.CCR-06-3045. Clin Cancer Res. 2007. PMID: 17671126

8

Chemotherapy-induced nausea and vomiting in breast cancer patients: a prospective observational study.

Booth CM, Clemons M, Dranitsaris G, Joy A, Young S, Callaghan W, Trudeau M, Petrella T. Booth CM, et al. J Support Oncol. 2007 Sep;5(8):374-80. J Support Oncol. 2007. PMID: 17944146

9

Adjuvant/neoadjuvant trastuzumab therapy in women with HER-2/neu-overexpressing breast cancer: a systematic review.

Madarnas Y, Trudeau M, Franek JA, McCready D, Pritchard KI, Messersmith H. Madarnas Y, et al. Cancer Treat Rev. 2008 Oct;34(6):539-57. doi: 10.1016/j.ctrv.2008.03.013. Epub 2008 May 27. Cancer Treat Rev. 2008. PMID: 18502589 Review.

10

Pattern of metastatic spread in triple-negative breast cancer.

Dent R, Hanna WM, Trudeau M, Rawlinson E, Sun P, Narod SA. Dent R, et al. Breast Cancer Res Treat. 2009 May;115(2):423-8. doi: 10.1007/s10549-008-0086-2. Epub 2008 Jun 10. Breast Cancer Res Treat. 2009. PMID: 18543098

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

235 results

Search Page